Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to assess if adding revumenib to standard chemotherapy improves outcomes in participants with AML with certain genetic mutations compared to chemotherapy alone. The study will also assess the safety of adding revumenib to chemotherapy.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Świeżo rozpoznana białaczka szpikowa, wcześniej nie leczona
- •Kwalifikacja do intensywnej chemioterapii
- •Obecność mutacji NPM1
- •Ogólny stan zdrowia pozwalający na udział w badaniu
- •Przewidywana długość przeżycia co najmniej 3 miesiące
- •Prawidłowa funkcja wątroby, nerek i serca
- •Ujemny test ciąży (dla kobiet w wieku rozrodczym)
✗ Disqualifies
- •Rozpoznana promieloblastyczna białaczka ostра
- •Nowotwór mózgu lub ośrodkowego układu nerwowego
- •Zaburzenia serca związane z wydłużonym czasem QT lub rodzinna historia takich zaburzeń
- •Problemy z jamy ustnej lub przełykiem mogące uniemożliwić przyjmowanie leku doustnego
- •Current nowotwór wymagający aktywnego leczenia (z wyjątkiem niektórych raków piersi i prostaty)
- •Niemożność połykania leków w postaci tabletek
- •Ciąża lub karmienie piersią
- •Hepatitis B, hepatitis C lub HIV z wykrywalnym wirusem
Simplified criteria — AI translation
Trial details
- Minimum age
- 12 Years
- Last updated (source)
- July 23, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (83)
Clinical Trial Site
Melbourne, Australia
Clinical Trial Site
Nedlands, Australia
Clinical Trial Site
Perth, Australia
Clinical Trial Site
Gosford, Australia
Clinical Trial Site
Wollongong, Australia
Clinical Trial Site
Sankt Pölten, Austria
Clinical Trial Site
Graz, Austria
Clinical Trial Site
Leoben, Austria
Clinical Trial Site
Linz, Austria
Clinical Trial Site
Ghent, Belgium
Clinical Trial Site
Fortaleza, Brazil
Clinical Trial Site
Barretos, Brazil
Clinical Trial Site
Jaú, Brazil
Clinical Trial Site
Porto Alegre, Brazil
Clinical Trial Site
Montreal, Canada
Clinical Trial Site
Toronto, Canada
Clinical Trial Site
Angers, France
Clinical Trial Site
Bayonne, France
Clinical Trial Site
Bordeaux, France
Clinical Trial Site
Batumi, Georgia
Clinical Trial Site
Tbilisi, Georgia
Clinical Trial Site 1
Tbilisi, Georgia
Clinical Trial Site 2
Tbilisi, Georgia
Clinical Trial Site
Tbilisi, Georgia
Clinical Trial Site
Tübingen, Germany
Clinical Trial Site
Düsseldorf, Germany
Clinical Trial Site
Herne, Germany
Clinical Trial Site
Jena, Germany
Clinical Trial Site
Hamburg, Germany
Clinical Trial Site
Győr, Hungary
Clinical Trial Site
Petah Tikva, Israel
Clinical Trial Site
Tel Aviv, Israel
Clinical Trial Site
Haifa, Israel
Clinical Trial Site
Jerusalem, Israel
Clinical Trial Site
Jerusalem, Israel
Clinical Trial Site
Monza, Italy
Clinical Trial Site
Alessandria, Italy
Clinical Trial Site
Bergamo, Italy
Clinical Trial Site
Bologna, Italy
Clinical Trial Site
Candiolo, Italy
Clinical Trial Site
Florence, Italy
Clinical Trial Site
Meldola, Italy
Clinical Trial Site
Milan, Italy
Clinical Trial Site
Milan, Italy
Clinical Trial Site
Palermo, Italy
Clinical Trial Site
Pavia, Italy
Clinical Trial Site
Perugia, Italy
Clinical Trial Site
Rimini, Italy
Clinical Trial Site
Roma, Italy
Clinical Trial Site
Udine, Italy
Clinical Trial Site
Johor Bahru, Malaysia
Clinical Trial Site
Petaling Jaya, Malaysia
Clinical Trial Site
Subang Jaya, Malaysia
Clinical Trial Site
Târgu Mureş, Romania
Clinical Trial Site
Bucharest, Romania
Clinical Trial Site
Bucharest, Romania
Clinical Trial Site
Cluj-Napoca, Romania
Clinical Trial Site
Iași, Romania
Clinical Trial Site
Busan, South Korea
Clinical Trial Site
Busan, South Korea
Clinical Trial Site
Goyang-si, South Korea
Clinical Trial Site
Seoul, South Korea
Clinical Trial Site
Seoul, South Korea
Clinical Trial Site
Las Palmas de Gran Canaria, Spain
Clinical Trial Site
Oviedo, Spain
Clinical Trial Site
Badalona, Spain
Clinical Trial Site
Barcelona, Spain
Clinical Trial Site
Burgos, Spain
Clinical Trial Site
Cáceres, Spain
Clinical Trial Site
Granada, Spain
Clinical Trial Site
Madrid, Spain
Clinical Trial Site
Madrid, Spain
Clinical Trial Site
Madrid, Spain
Clinical Trial Site
Málaga, Spain
Clinical Trial Site
Palma, Spain
Clinical Trial Site
Pamplona, Spain
Clinical Trial Site
Seville, Spain
Clinical Trial Site
Valencia, Spain
Clinical Trial Site
Aberdeen, United Kingdom
Clinical Trial Site
Derby, United Kingdom
Clinical Trial Site
Lincoln, United Kingdom
Clinical Trial Site
London, United Kingdom
Clinical Trial Site
Sutton, United Kingdom
Trial contact
Syndax Pharmaceuticals
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/24/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.